Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload (Q46151811)

20 December 2017

title

Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload (English)

1 reference

20 December 2017

0 references

13

Jeanne Mialet-Perez

1 reference

PubMed ID

19162038

20 December 2017

Céline Guilbeau-Frugier

6

object named as

Céline Guilbeau-Frugier

1 reference

20 December 2017

Olivier Lairez

1

1 reference

20 December 2017

Denis Calise

2

1 reference

20 December 2017

Pascale Bianchi

3

1 reference

20 December 2017

Catherine Ordener

4

1 reference

20 December 2017

Odile Spreux-Varoquaux

5

1 reference

20 December 2017

Ghislaine Escourrou

7

1 reference

20 December 2017

Isabelle Seif

8

1 reference

20 December 2017

Jérôme Roncalli

9

1 reference

20 December 2017

Nathalie Pizzinat

10

1 reference

20 December 2017

Michel Galinier

11

1 reference

20 December 2017

Angelo Parini

12

1 reference

20 December 2017

publication date

7 January 2009

1 reference

20 December 2017

Journal of Molecular and Cellular Cardiology

published in

1 reference

20 December 2017

volume

46

1 reference

20 December 2017

page(s)

587-595

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Long-term serotonin administration induces heart valve disease in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Serotonin responsiveness through 5-HT2A and 5-HT4 receptors is differentially regulated in hypertrophic and failing rat cardiac ventricle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Appearance of a ventricular 5-HT4 receptor-mediated inotropic response to serotonin in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

New directions in monoamine oxidase A and B selective inhibitors and substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Age-dependent increase in hydrogen peroxide production by cardiac monoamine oxidase A in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Differential age-related changes of MAO-A and MAO-B in mouse brain and peripheral organs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

A comparative study of the expression of monoamine oxidase-A and -B mRNA and protein in non-CNS human tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Identification of a core set of genes that signifies pathways underlying cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

In vivo bradykinin B2 receptor activation reduces renal fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

[3H]MDL 100,907: a novel selective 5-HT2A receptor ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Serotonin metabolism in the normal and failing hamster heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Receptor mechanisms involved in the 5-HT-induced inotropic action in the rat isolated atrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-kappaB in cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Effects of ketanserin on left ventricular hypertrophy in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

5-HT2A and 5-HT2C receptors and their atypical regulation properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

A new hypertrophic mechanism of serotonin in cardiac myocytes: receptor-independent ROS generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.12.017

10.1016/J.YJMCC.2008.12.017

7 January 2021

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

19162038

1 reference

20 December 2017